Viglacera Tien Son JSC (HNX:VIT)
Vietnam · Delayed Price · Currency is VND 18,700
+200 (1.08%)
At close: Aug 4, 2025
Marinus Pharmaceuticals Revenue
Viglacera Tien Son JSC had revenue of 548.83B VND in the quarter ending June 30, 2025, with 8.60% growth. This brings the company's revenue in the last twelve months to 2.18T, up 4.13% year-over-year. In the year 2024, Viglacera Tien Son JSC had annual revenue of 2.14T with 7.25% growth.
Revenue (ttm)
2,181.83B
Revenue Growth
+4.13%
P/S Ratio
0.43
Revenue / Employee
2.28B
Employees
955
Market Cap
934.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,143.14B | 144.92B | 7.25% |
| Dec 31, 2023 | 1,998.23B | -3.07B | -0.15% |
| Dec 31, 2022 | 2,001.30B | 744.50B | 59.24% |
| Dec 31, 2021 | 1,256.80B | -216.55B | -14.70% |
| Dec 31, 2019 | 1,473.35B | 228.43B | 18.35% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition